Literature DB >> 1670196

Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience.

M Petri1, D Howard, J Repke.   

Abstract

To determine whether pregnancy is associated with an increased rate of flare in patients with systemic lupus erythematosus (SLE), we prospectively studied 40 pregnancies in 37 women with SLE. The women were evaluated on a monthly basis in the Hopkins Lupus Pregnancy Center. Flare was designated using a previously developed quantitative definition, i.e., a change of greater than 1.0 in the physician's global assessment (scale of 0-3) since the preceding visit or during the last 93 days. Flare occurred in 24 (60%) of the pregnancies. Flares presented most commonly as constitutional symptoms, renal involvement, or involvement of skin or joints. Comparison of the rates of flare in the same patients after delivery and in nonpregnant SLE patients showed a significant increase in the rate of flare during pregnancy (P less than 0.001 and P less than 0.0001, respectively). We conclude that flare of lupus during pregnancy is common and occurs significantly more frequently than does flare in nonpregnant SLE patients or in the same patients after pregnancy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670196     DOI: 10.1002/art.1780341210

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  57 in total

1.  Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre.

Authors:  D L Huong; B Wechsler; D Vauthier-Brouzes; H Beaufils; G Lefebvre; J C Piette
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  The de novo diagnosis of systemic lupus erythematosus and lupus nephritis during pregnancy.

Authors:  Tapan Patel; Andrew Fenves; Gates Colbert
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-04

3.  Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity.

Authors:  Amr H Sawalha; Lu Wang; Ajay Nadig; Emily C Somers; W Joseph McCune; Travis Hughes; Joan T Merrill; R Hal Scofield; Faith M Strickland; Bruce Richardson
Journal:  J Autoimmun       Date:  2012-02-03       Impact factor: 7.094

4.  Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy.

Authors:  Miguel A Saavedra; Claudia Cruz-Reyes; Olga Vera-Lastra; Griselda T Romero; Polita Cruz-Cruz; Rafael Arias-Flores; Luis J Jara
Journal:  Clin Rheumatol       Date:  2012-01-27       Impact factor: 2.980

Review 5.  Lupus and pregnancy: complex yet manageable.

Authors:  Josephine Patricia Dhar; Robert J Sokol
Journal:  Clin Med Res       Date:  2006-12

6.  Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.

Authors:  Stephen J Balevic; Michael Cohen-Wolkowiez; Amanda M Eudy; Thomas P Green; Laura E Schanberg; Megan E B Clowse
Journal:  J Rheumatol       Date:  2018-10-01       Impact factor: 4.666

Review 7.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 8.  Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution.

Authors:  Graziela Carvalheiras; Pedro Vita; Susana Marta; Rita Trovão; Fátima Farinha; Jorge Braga; Guilherme Rocha; Isabel Almeida; António Marinho; Teresa Mendonça; Paulo Barbosa; João Correia; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 9.  Management of pregnancy in systemic lupus erythematosus.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

10.  17beta-estradiol enhances the response of plasmacytoid dendritic cell to CpG.

Authors:  Xiaoxi Li; Yixin Xu; Ling Ma; Lingyun Sun; Gengfeng Fu; Yayi Hou
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.